🌞Imagine… A Pacific Future with Early and Accurate Detection of Skin Cancer🌞
The Pacific region has successfully adopted the FDA-cleared device that uses artificial intelligence to non-invasively detect skin cancer in the primary care setting. The region has fostered a culture of prevention, awareness, and collaboration, where patients and health care providers can easily and quickly diagnose skin cancer and initiate appropriate treatment.
Bassett, M. (2024). FDA clears AI-powered non-invasive skin cancer detector. MedPage Today.
💥 What’s the Big Deal:
The article by Bassett (2024) reveals that the FDA cleared an artificial-intelligence (AI)-powered device designed to non-invasively detect skin cancer in the primary care setting. 🌡️ Developer DermaSensor said the device uses AI-powered spectroscopy technology to non-invasively evaluate cellular and subcellular characteristics of a lesion for any of the three types of skin cancers – melanoma, basal cell carcinoma, and squamous cell carcinoma. 🙌 The wireless, handheld device then provides a result in real time using an FDA-cleared algorithm. Skin cancer is a challenge for the Pacific region, as it affects the health and well-being of its residents, especially those who are exposed to high levels of ultraviolet radiation from the sun. By adopting the FDA-cleared device, the Pacific region can enhance its early and accurate detection of skin cancer, and reduce the risk of morbidity and mortality. 🌅The device can also support the region’s prevention, awareness, and collaboration, and enable more patients and health care providers to access and use a simple and effective diagnostic tool.
#SkinCancer #PacificFuture #AIDetector #Prevention #Collaboration